Your session is about to expire
← Back to Search
laser treatment for Vulvar Atrophy
Study Summary
This trial will test how well a new laser therapy works to treat Genitourinary Syndrome of Menopause (GSM) in post-menopausal women.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the eligibility criteria for participation in this trial?
"This medical study is searching for 60 women aged 45-70 suffering from vulval atrophy. In addition to this, these potential patients must have not received any treatments for genitourinary syndrome of menopause in the past three months and need to be willing and able to comply with trial protocol. Lastly, participants must report experiencing at least one moderate or severe symptom such as dryness, itching, irritation pain/soreness or dyspareunia during the last 30 days at least once a week."
What is the current participant capacity of this experiment?
"Affirmative. According to the information documented on clinicaltrials.gov, this medical experiment is in full swing and looking for participants. It was first advertised on August 1st 2019 with its most recent changes being made October 17th 2022. Sixty patients are needed from a single study site."
Are there still opportunities for people to join this experiment?
"That is correct. According to the particulars of this trial hosted on clinicaltrials.gov, it began recruitment on August 1st 2019 and was most recently updated on October 17th 2022. The investigation requires a total of 60 volunteers from one location."
Does the protocol of this clinical trial allow applicants who are younger than 80 years old to participate?
"The age window for this research project specifies a minimum of 45 years old and maximum of 70. However, there are also 42 studies that accommodate minors and 138 trials available to those over 65."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger